Assessing Changes in Myocardial Tissue and Blood in Patients With Advanced Heart Disease
Launched by UNIVERSITY OF UTAH · Apr 6, 2010
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying changes in heart tissue and blood in patients with advanced heart disease, specifically those with congestive heart failure. The researchers are looking to collect samples from patients who are undergoing procedures like a left ventricular assist device (LVAD) implantation or heart transplantation. They will also gather samples from a small number of healthy donors to compare the data. The goal is to better understand the science behind heart disease, which may help improve treatment in the future.
To be eligible for this study, participants need to be at least 18 years old and diagnosed with heart failure, or between 13 to 18 years old if they are large enough for an LVAD. It’s important for participants or their representatives to understand English and be willing to give consent to take part in the study. If you join, there won’t be any new treatments or procedures involved; instead, your data and samples will be stored for future research. This project aims to gather important information about heart failure that could benefit others down the line.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • \>18 years of age diagnosed with heart failure undergoing either LVAD implantation or heart transplantation
- • 13 to 18 years of age, specifically, older children with heart failure whose body mass index is large enough to accommodate and LVAD
- Exclusion Criteria:
- • Neither patient nor patient representative understands spoken English
- • Neither patient nor patient's personal representative is willing to give written consent for participation.
About University Of Utah
The University of Utah is a prestigious research institution known for its commitment to advancing medical knowledge and improving patient care through innovative clinical trials. With a robust infrastructure that supports a wide range of biomedical research initiatives, the university leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies. By fostering collaboration among researchers, clinicians, and community partners, the University of Utah aims to translate scientific discoveries into effective therapies and interventions, ultimately enhancing health outcomes and contributing to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Salt Lake City, Utah, United States
Richmond, Virginia, United States
Salt Lake City, Utah, United States
Murray, Utah, United States
Patients applied
Trial Officials
Stavros Drakos, M.D., Ph.D.
Principal Investigator
University of Utah Health Sciences Center & VA Salt Lake City Health Care System
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials